(Q52067430)

21 April 2018

title

Impact of endoscopic therapy on the survival of patients with primary sclerosing cholangitis. (English)

1 reference

21 April 2018

primary sclerosing cholangitis

main subject

ascending cholangitis

0 references

patient

0 references

1 reference

A R Baluyut

1

1 reference

21 April 2018

S Sherman

2

1 reference

21 April 2018

G A Lehman

3

1 reference

21 April 2018

H Hoen

4

1 reference

21 April 2018

N Chalasani

5

1 reference

21 April 2018

language of work or name

English

0 references

publication date

1 March 2001

1 reference

21 April 2018

Gastrointestinal Endoscopy

published in

1 reference

21 April 2018

volume

53

1 reference

21 April 2018

issue

3

1 reference

21 April 2018

page(s)

308-312

1 reference

21 April 2018

Primary sclerosing cholangitis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2801%2970403-8

Ursodiol for primary sclerosing cholangitis. Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2801%2970403-8

Toward better treatment of primary sclerosing cholangitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2801%2970403-8

Nonoperative dilatation of dominant strictures in primary sclerosing cholangitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2801%2970403-8

Endoscopic treatment of biliary tract strictures in sclerosing cholangitis: a larger series and recommendations for treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2801%2970403-8

Therapeutic investigations in primary sclerosing cholangitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2801%2970403-8

Endoscopic and radiologic approaches to therapy in primary sclerosing cholangitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2801%2970403-8

Transection of the oesophagus for bleeding oesophageal varices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2801%2970403-8

The relative role of the Child-Pugh classification and the Mayo natural history model in the assessment of survival in patients with primary sclerosing cholangitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2801%2970403-8

Efficacy of ursodeoxycholic acid treatment and endoscopic dilation of major duct stenoses in primary sclerosing cholangitis. An 8-year prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2801%2970403-8

Liver transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: predicting outcomes with natural history models.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2801%2970403-8

Optimal timing of liver transplantation for primary biliary cirrhosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2801%2970403-8

Utilization of the Mayo risk score in patients with primary biliary cirrhosis receiving ursodeoxycholic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2801%2970403-8

Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2801%2970403-8

10.1016/S0016-5107(01)70403-8

7 January 2021

Identifiers

DOI

1 reference

21 April 2018

1 reference

21 April 2018